America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Learn which fund family offers the best Sharpe ratio indices and why it matters for risk-adjusted performance. Compare funds to identify strong performers.
28,055 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Investors are shifting focus from Intel to overlooked chip stocks delivering real cash flow and AI-driven demand, led...
Gas costs are lifting travel bills for Memorial Day weekend, with households facing higher pump prices and investors ...
A practical, reader-friendly guide to interpreting Xunlei's Q1 2026 earnings. Learn what to watch, how to model resul...
Trad.Fi and W3 unveil a four-year plan to put a $650 million private-credit pipeline on blockchain rails, aiming to c...
Ripple's chief executive pushes back on BTC-focused tactics, praising XRP's utility. The remarks come as Strategy's S...
As U.S.–Iran tensions flare, energy prices surge and corporate boards adjust risk, liquidity and strategy in a newly ...
New Mexico moves to examine decades of coerced sterilizations in Native communities, with findings due by 2027. The i...
Plug Power stock popped after-hours following a strong Q4 showing and raised 2026 guidance. This article breaks down ...
Strive raises the dividend on SATA preferred stock to 12.75% and deploys $50 million into Strategy's STRC, while incr...
A tiny $1,800 token purchase has triggered a governance attack on Moonwell, risking over $1 million in funds. Analyst...
A leading voice in personal finance questions the premise of hitting a $1 million target by age 25, urging young adul...